These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12444359)

  • 21. Treatment for substance use disorders in a privately insured population under managed care: costs and services use.
    Greenfield SF; Azzone V; Huskamp H; Cuffel B; Croghan T; Goldman W; Frank RG
    J Subst Abuse Treat; 2004 Dec; 27(4):265-75. PubMed ID: 15610828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity.
    Chen S; Barnett PG; Sempel JM; Timko C
    J Subst Abuse Treat; 2006 Jul; 31(1):95-105. PubMed ID: 16814015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost estimation when time and resources are limited: the Brief DATCAP.
    French MT; Roebuck MC; McLellan AT
    J Subst Abuse Treat; 2004 Oct; 27(3):187-93. PubMed ID: 15501371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings.
    McCollister KE; French MT
    Addiction; 2003 Dec; 98(12):1647-59. PubMed ID: 14651494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parenting self-efficacy and empowerment among expectant mothers with substance use disorders.
    Zand DH; Chou JL; Pierce KJ; Pennington LB; Dickens RR; Michael J; McNamara D; White T
    Midwifery; 2017 May; 48():32-38. PubMed ID: 28324807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residential substance abuse treatment for pregnant and postpartum women and their children: treatment and policy implications.
    Clark HW
    Child Welfare; 2001; 80(2):179-98. PubMed ID: 11291900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Service-level costing of drug abuse treatment.
    Anderson DW; Bowland BJ; Cartwright WS; Bassin G
    J Subst Abuse Treat; 1998; 15(3):201-11. PubMed ID: 9633032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of time in treatment on the employment and earnings of drug abusers.
    French MT; Zarkin GA; Hubbard RL; Rachal JV
    Am J Public Health; 1991 Jul; 81(7):904-7. PubMed ID: 1905111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments.
    Zavala SK; French MT; Henderson CE; Alberga L; Rowe C; Liddle HA
    J Subst Abuse Treat; 2005 Oct; 29(3):191-205. PubMed ID: 16183468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parenting training for women in residential substance abuse treatment. Results of a demonstration project.
    Camp JM; Finkelstein N
    J Subst Abuse Treat; 1997; 14(5):411-22. PubMed ID: 9437610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
    Thompson KM; Tebbens RJ
    Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.
    Parthasarathy S; Weisner CM
    Drug Alcohol Depend; 2005 Nov; 80(2):231-40. PubMed ID: 15916868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Family-focused substance abuse treatment: a program evaluation.
    McComish JF; Greenberg R; Ager J; Essenmacher L; Orgain LS; Bacik WJ
    J Psychoactive Drugs; 2003; 35(3):321-31. PubMed ID: 14621130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment setting and baseline substance use severity interact to predict patients' outcomes.
    Tiet QQ; Ilgen MA; Byrnes HF; Harris AH; Finney JW
    Addiction; 2007 Mar; 102(3):432-40. PubMed ID: 17298651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study.
    Humphreys K; Moos R
    Alcohol Clin Exp Res; 2001 May; 25(5):711-6. PubMed ID: 11371720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance abusing mothers in residential treatment with their babies: postnatal psychiatric symptomatology and its association with mother-child relationship and later need for child protection actions.
    Pajulo M; Pyykkönen N; Kalland M; Sinkkonen J; Helenius H; Punamäki RL
    Nord J Psychiatry; 2011 Feb; 65(1):65-73. PubMed ID: 20586677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
    Matthews H; Kelly PJ; Deane FP
    Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of managed behavorial healthcare on the costs of psychiatric and chemical dependency treatment.
    Geraty R; Bartlett J; Hill E; Lee F; Shusterman A; Waxman A
    Behav Healthc Tomorrow; 1994; 3(2):18-30. PubMed ID: 10172255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The perinatal outcome of children born to women with substance dependence detoxified in residential treatment during pregnancy.
    Haabrekke KJ; Slinning K; Walhovd KB; Wentzel-Larsen T; Moe V
    J Addict Dis; 2014; 33(2):114-23. PubMed ID: 24717065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unmet substance abuse treatment need, health services utilization, and cost: a population-based emergency department study.
    Rockett IR; Putnam SL; Jia H; Chang CF; Smith GS
    Ann Emerg Med; 2005 Feb; 45(2):118-27. PubMed ID: 15671966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.